Report finds eating disorder rates up 71% since 1990, as clinicians flag GLP-1 drug risks
A new report cited by MIT Technology Review's The Checkup newsletter finds that global cases of anorexia nervosa and bulimia nervosa increased 71% between 1990 and 2023. Clinicians quoted in the report say they are already observing GLP-1 weight-loss drugs worsening disordered eating in some patients.